Argyle Capital Partners, LLC
- SEC CIK
- 0002079995
- Latest filing
- Aug 7, 2026
PFE holding history
Pfizer Inc in every 13F filed by Argyle Capital Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 13,411
- Value
- $322.9K
- % of portfolio
- 0.2%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 13,411 | $322.9K | 0.2% | −1,099−7.6% | Reduced | Holders |
| Q1 2026 | 14,510 | $407.4K | 0.3% | +606+4.4% | Added | Holders |
| Q4 2025 | 13,904 | $346.2K | 0.3% | +1,261+10.0% | Added | Holders |
| Q3 2025 | 12,643 | $322.1K | 0.2% | −1,330−9.5% | Reduced | Holders |
| Q2 2025 | 13,973 | $338.7K | 0.3% | +1,686+13.7% | Added | Holders |
| Q1 2025 | 12,287 | $311.3K | 0.3% | −1,795−12.7% | Reduced | Holders |
| Q4 2024 | 14,082 | $373.6K | 0.3% | – | No prior filing | Holders |